Does a left ventricular assist device and specific pharmacologic regimen improve sustained reversal of severe heart failure in selected patients with severe heart failure secondary to nonischemic cardiomyopathy?
A combination of a left ventricular assist device and specific pharmacologic therapy can achieve sustained reversal of severe heart failure in selected patients with nonischemic cardiomyopathy.
In this single-center study, we found that sustained reversal of severe heart failure secondary to nonischemic cardiomyopathy could be achieved in selected patients with the use of a left ventricular assist device and a specific pharmacologic regimen.
Birks et al. (2006) studied this question.